According to Strides Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.97314. At the end of 2023 the company had a P/S ratio of 1.53.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.53 | 77.03% |
2022 | 0.8646 | -34.05% |
2021 | 1.31 | -52.02% |
2020 | 2.73 | 147.73% |
2019 | 1.10 | -39.42% |
2018 | 1.82 | -30.15% |
2017 | 2.61 | -7.77% |
2016 | 2.83 | -9.71% |
2015 | 3.13 |